European Heart Journal Advance Access published online on April 8, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi226
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cardiovascular Diseases (MBC-16), King Faisal Specialist Hospital and Research Centre,PO Box 3354, Riyadh 11211, Saudi Arabia
* To whom correspondence should be addressed. Aims To assess the long-term outcome of mitral balloon valvotomy (MBV) and identify predictors of restenosis- and event-free survival. Methods and results We report the immediate and long-term clinical and echocardiographic results in 493 patients, mean age 31±11, who underwent successful MBV and were followed-up for 0.5-15 years (median 5±3) with clinical and echocardiographic examination. After MBV, mitral valve area increased from 0.84±0.2 to 1.83±0.53 cm2 (P<0.0001) as measured by catheter and from 0.92±0.17 to 1.96±0.29 cm2 as measured by two-dimensional echo. Restenosis occurred in 86/493 (17.4%) patients and it was less frequent in patients with low echo score. Actuarial freedom from restenosis at 5, 7, 10, and 13 years were 89±1, 81±2, 68±3, and 51±6%, respectively, and was significantly higher in patients with low echo score. Event-free survival (death, redo MBV, mitral valve replacement, New York Heart Association functional Class III or IV) at 5, 7, 10, and 13 years were 92±1, 87±2, 80±3, and 74±3%, respectively, and was significantly higher for patients with low echo score. Cox regression analysis identified mitral echocardiographic score (MES) >8 as predictors of restenosis (P=0.0004) and MES and age as predictors of event-free survival (P=0.0003 and 0.004, respectively). Conclusion MBV has excellent long-term results for selected patients with mitral stenosis. The long-term outcome after this procedure can be predicted from baseline clinical and valvular characteristics.
Received September 14, 2004
Revised February 13, 2005
Accepted February 17, 2005
Clinical research
Long-term clinical and echocardiographic results after successful mitral balloon valvotomy and predictors of long-term outcome
2 Biostatistics, Epidemiology and Scientific Computing Department, King Faisal Specialist Hospitaland Research Center, PO Box 3354, Riyadh 11211, Saudi Arabia
Mohamed Eid Fawzy, E-mail: fawzy100{at}hotmail.com
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-K. Song, J.-M. Song, D.-H. Kang, S.-C. Yun, D. W. Park, S. W. Lee, Y.-H. Kim, C. W. Lee, M.-K. Hong, J.-J. Kim, et al. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an important prognosticator Eur. Heart J., May 2, 2009; 30(10): 1254 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 23, 2007; 49(3): 361 - 374. [Full Text] [PDF] |
||||

